• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

36th General Conference of the International Scientific Council for Trypanosomiasis Research and Control

17-22 September 2023

Mombasa, Kenya

The 36th General Conference of the International Scientific Council for Trypanosomiasis Research and Control (ISCTRC) will be organised by the ISCTRC Council, comprising the Africa Union Member States, Africa Union Pan African Tsetse and Trypanosomiasis Eradication Campaign (AU-PATTEC), International organizations, including Food and Agricultural Organization (FAO), World Health Organization (WHO), and the International Atomic Energy Agency (IAEA). The conference aims to facilitate information sharing on tsetse, human and animal trypanosomiasis problem, review control strategies, and recommend appropriate approaches for tsetse and trypanosomiasis research and control.

Session

This session includes discussion of HAT diagnosis, HAT screening strategies and elimination, HAT treatment and vaccines, and HAT animal reservoir and vector control in HAT elimination

Moderator: Florent Mbo Kuikumbi, Access Leader and HAT Platform Coordinator, DNDi
Rapporteur: Charles Wamboga, Uganda Ministry of Health

19 September 2023
14:00 – 14:10
Active search strategy for human African trypanosomiasis cases (HAT) in villages without new cases for 10 years by a health district team
Nkieri M*, Mukuba M, Nganzobo P, Basake K, Mutuy B, Mwamba E, Donen P, Labat A, Mitashi P, Mbo F
14:10 – 14:20Human African Trypanosomiasis challenge and perspective of unconfirmed serological
Rashidi Assani S*, Tshowa J, Mbo F, Panya A, Miaka E
14:20 – 14:30Active search for unconfirmed HAT serologically positive individuals with trypanolysis test from 2019 to 2022 in the Democratic Republic of Congo
Nyembo A*, Ngolo D, Valverde O, Bilonda A, Dinanga J, Pyana P, Fukinsia A, Nganzobo P, Tshowa J, Miaka C, Mwamba E, Mbo F
20 September 2023
8:45 – 8:55
Access to Fexinidazole, a new oral drug against T.b gambiense HAT in the context of the COVID-19 pandemic in the DRC: January 2020 to December 2021
Ngolo D*, Mbo F, Mutombo W, Bilonda A, Nyembo A, Fukinsia A, Nganzobo P, Tshowa J, Rachidi S, Kavunga P, Munganga J, Miaka E, Tarral A, Valverde O
8:55 – 9:05Perspectives for the introduction of fexinidazole to treat r-HAT: HAT-r-ACC project results
Valverde O*; Alves D, Perdrieu C, Lemerani M, Nyirenda W, Eriatu A, Wamboga C, Seixas J , Lejon V , Signorell A, Baudin E, Matovu E
9:05-9:25Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial
Kande Betu Kumeso V, Mutombo W, Rembry S, Valverde O, Ngolo D, Prêtre A, Camara M, Catusse J, Schneitter S, Nusbaumer M, Mwamba Miaka E, Scherrer B, Strub-Wourgaft N, Tarral A
*Presenting authors

Side event

HAT Platform Steering Committee Meeting

Date: Saturday, 16 September 2023

The HAT Platform is organizing its Steering Committee Meeting on the sidelines of the 36th ISCTRC General Conference bringing together various experts from the national HAT programmes of the member countries of the platform and various partners involved in the fight against sleeping sickness.

Sleeping sickness

Other events

Loading...
15-20 June 2025

Kigali, Rwanda

Twelfth EDCTP Forum

15-18 June 2025

Manila, Philippines

8th Asia Dengue Summit

22 May 2025

Online event

MSF Scientific Days

21 May 2025, 9-10:30 AM

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License